Vdyne is set to launch a pivotal trial for its transcatheter tricuspid valve replacement system, aiming to address severe ...
Detailed price information for Smurfit Westrock Plc (SW-N) from The Globe and Mail including charting and trades.
The science of a perfect espresso. How AI can help treat heart disease. NASA’s on its way back to the Moon. All that and more ...
A valve-in-valve procedure for dysfunctional bioprosthetic mitral valves had lower 1-year risk for death and stroke than redo ...
From Iran to China, President Trump’s global aggression has encouraged other countries to search for new ways to pressure the ...
Zacks Investment Research on MSN
Tempus AI stock gains following the ALERT trial result announcement
Tempus AI, Inc. TEM recently presented results from the ALERT (addressing undertreatment and health equity in aortic stenosis and mitral regurgitation using an integrated ehr platform) trial at the ...
Zacks Investment Research on MSN
JNJ Q1 MedTech preview: Key drivers and China headwinds to watch
Johnson & Johnson's JNJ MedTech division, which spans orthopedics, surgery, cardiovascular and vision care, contributes ...
Discover how medtech companies are leveraging data and hardware to drive AI advancements, improve clinical outcomes, and ...
The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...
Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
Victor Stefanescu reports on the business of food, anchoring the Minnesota Star Tribune's coverage of agriculture and large companies such as General Mills and Cargill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results